- Home
- CELZ vs EVGN Comparison
CELZ vs EVGN Comparison
Compare CELZ & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- EVGN
- Stock Information
- Founded
- CELZ 1998
- EVGN 1999
- Country
- CELZ United States
- EVGN Israel
- Employees
- CELZ N/A
- EVGN N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- CELZ Health Care
- EVGN Industrials
- Exchange
- CELZ Nasdaq
- EVGN Nasdaq
- Market Cap
- CELZ 10.4M
- EVGN 10.9M
- IPO Year
- CELZ N/A
- EVGN N/A
- Fundamental
- Price
- CELZ $5.59
- EVGN $1.31
- Analyst Decision
- CELZ
- EVGN Strong Buy
- Analyst Count
- CELZ 0
- EVGN 1
- Target Price
- CELZ N/A
- EVGN $3.50
- AVG Volume (30 Days)
- CELZ 88.8K
- EVGN 150.4K
- Earning Date
- CELZ 11-12-2025
- EVGN 11-20-2025
- Dividend Yield
- CELZ N/A
- EVGN N/A
- EPS Growth
- CELZ N/A
- EVGN N/A
- EPS
- CELZ N/A
- EVGN N/A
- Revenue
- CELZ $6,000.00
- EVGN $9,444,000.00
- Revenue This Year
- CELZ N/A
- EVGN N/A
- Revenue Next Year
- CELZ N/A
- EVGN $12.35
- P/E Ratio
- CELZ N/A
- EVGN N/A
- Revenue Growth
- CELZ N/A
- EVGN 42.25
- 52 Week Low
- CELZ $1.69
- EVGN $0.95
- 52 Week High
- CELZ $6.90
- EVGN $2.87
- Technical
- Relative Strength Index (RSI)
- CELZ 82.55
- EVGN 54.40
- Support Level
- CELZ $3.35
- EVGN $1.21
- Resistance Level
- CELZ $4.23
- EVGN $1.32
- Average True Range (ATR)
- CELZ 0.40
- EVGN 0.08
- MACD
- CELZ 0.20
- EVGN -0.00
- Stochastic Oscillator
- CELZ 77.63
- EVGN 36.03
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.